| A framework for the development of guidelines for the management of glucocorticoid-induced osteoporosis | Osteoporosis International | 2012 | 233 |
| Test-retest reliability of evoked BOLD signals from a cognitive-emotive fMRI test battery | NeuroImage | 2012 | 216 |
| Treatment failure in osteoporosis | Osteoporosis International | 2012 | 144 |
| Unbiased comparison of sample size estimates from longitudinal structural measures in ADNI | Human Brain Mapping | 2012 | 73 |
| Features of subsyndromal and persistent delirium | British Journal of Psychiatry | 2012 | 69 |
| Effects of vildagliptin on postprandial markers of bone resorption and calcium homeostasis in recently diagnosed, well-controlled type 2 diabetes patients | Journal of Diabetes | 2012 | 43 |
| Tadalafil for the Treatment of Lower Urinary Tract Symptoms in Japanese Men with Benign Prostatic Hyperplasia: Results from a 12-week Placebo-controlled Dose-finding Study with a 42-week Open-label Extension | LUTS: Lower Urinary Tract Symptoms | 2012 | 32 |
| A study comparing insulin lispro mix 25 with glargine plus lispro therapy in patients with Type 2 diabetes who have inadequate glycaemic control on oral anti-hyperglycaemic medication: results of the PARADIGM study | Diabetic Medicine | 2012 | 30 |
| A randomized non-inferiority study comparing the addition of exenatide twice daily to sitagliptin or switching from sitagliptin to exenatide twice daily in patients with type 2 diabetes experiencing inadequate glycaemic control on metformin and sitagliptin | Diabetic Medicine | 2012 | 30 |
| An appendix to the 2012 IOF-ECTS guidelines for the management of glucocorticoid-induced osteoporosis | Archives of Osteoporosis | 2012 | 29 |
| A phase II trial of second-line pemetrexed in adults with advanced/metastatic osteosarcoma | European Journal of Cancer | 2012 | 27 |
| Early switch strategy in patients with major depressive disorder: a double-blind, randomized study | Journal of Clinical Psychopharmacology | 2012 | 27 |
| A randomized, phase 2 study comparing pemetrexed plus best supportive care versus best supportive care as maintenance therapy after first-line treatment with pemetrexed and cisplatin for advanced, non-squamous, non-small cell lung cancer | BMC Cancer | 2012 | 22 |
| Quantitative measurement of cell-free plasma DNA and applications for detecting tumor genetic variation and promoter methylation in a clinical setting | Journal of Molecular Diagnostics | 2012 | 20 |
| Typical and atypical clinical presentation of uterine myomas | Journal of the Chinese Medical Association | 2012 | 19 |
| Atomoxetine once daily for 24 weeks in adults with attention-deficit/hyperactivity disorder (ADHD): impact of treatment on family functioning | Clinical Neuropharmacology | 2012 | 16 |
| Early vs. conventional switching of antidepressants in patients with MDD and moderate to severe pain: a double-blind randomized study | Journal of Affective Disorders | 2012 | 15 |
| Open-label treatment with olanzapine for patients with borderline personality disorder | Journal of Clinical Psychopharmacology | 2012 | 15 |
| Classical markers like ER and ki-67, but also survivin and pERK, could be involved in the pathological response to gemcitabine, adriamycin and paclitaxel (GAT) in locally advanced breast cancer patients: results from the GEICAM/2002-01 phase II study | Clinical and Translational Oncology | 2012 | 14 |
| Somatic mutations in CCK2R alter receptor activity that promote oncogenic phenotypes | Molecular Cancer Research | 2012 | 13 |
| Glucocorticoid receptor gene polymorphisms are associated with reduced first-phase glucose-stimulated insulin secretion and disposition index in women, but not in men | Diabetic Medicine | 2012 | 12 |
| A systematic review of the safety information contained within the Summaries of Product Characteristics of medications licensed in the United Kingdom for Attention Deficit Hyperactivity Disorder. how does the safety prescribing advice compare with national guidance? | Child and Adolescent Psychiatry and Mental Health | 2012 | 12 |
| Applications of imaging biomarkers in the early clinical development of central nervous system therapeutic agents | Clinical Pharmacology and Therapeutics | 2012 | 11 |
| Osteoporosis treatment in postmenopausal women with pre-existing fracture | Taiwanese Journal of Obstetrics and Gynecology | 2012 | 10 |
| Health-related quality of life in ADHD: a pooled analysis of gender differences in five atomoxetine trials | ADHD Attention Deficit and Hyperactivity Disorders | 2012 | 8 |
